Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 9 open reading frame 64 pseudogene (ENSG00000270409) is a genomic sequence on human chromosome 9 that closely resembles a functional gene but contains disabling mutations and does not encode a functional protein product[2][4]. Such pseudogenes are remnants of gene duplication or retrotransposition events and, according to standard nomenclature and molecular biology definitions, lack protein-coding capacity and functional implications in physiology or drug action[2][4]. While a small minority of pseudogenes have been shown to be transcribed or play rare regulatory roles, this entry has no evidence for functional transcript or protein product and is not considered a therapeutic or biological target[1][4][6]. Pseudogenes can sometimes complicate molecular genetic studies, as their sequence similarity to real genes can interfere with assays, but this locus has no direct practical role in therapy, diagnosis, or molecular regulation[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 64 pseudogene.